Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,589 GBp
Change Today -36.00 / -2.22%
Volume 148.0K
SYR On Other Exchanges
Symbol
Exchange
OTC US
London
As of 11:35 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

synergy health plc (SYR) Snapshot

Open
1,596 GBp
Previous Close
1,625 GBp
Day High
1,624 GBp
Day Low
1,586 GBp
52 Week High
04/15/15 - 2,426 GBp
52 Week Low
10/10/14 - 1,372 GBp
Market Cap
940.0M
Average Volume 10 Days
114.6K
EPS TTM
0.57 GBp
Shares Outstanding
59.2M
EX-Date
08/6/15
P/E TM
27.9x
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNERGY HEALTH PLC (SYR)

Related News

No related news articles were found.

synergy health plc (SYR) Related Businessweek News

No Related Businessweek News Found

synergy health plc (SYR) Details

Synergy Health plc provides outsourced sterilization services for medical device manufacturers, hospitals, and other industries worldwide. It operates through three segments: Applied Sterilisation Technologies and Laboratory Services; Healthcare Services; and Healthcare Solutions. The company offers hospital sterilization services for the reusable medical and surgical equipment used in operating theatres. It also provides a range of sterilization technologies comprising gamma irradiation; electron, ion, and X-ray beam treatments; and ethylene oxide sterilization solutions for the medical devices, pharmaceuticals, and industrial sectors. In addition, the company offers reusable surgical solutions, such as gowns, towels, back table covers, reusable instrument wraps, sheets and liquid-proof drapes, stainless basin products, and set-up packs for hospitals and surgery centers; and laboratory services, including pathology, toxicology, microbiology, and food and allergen testing services, as well as drug and alcohol testing services. Further, it provides pharmaceutical laboratories for chemical and microbiological analysis; and linen management services for healthcare facilities. Additionally, the company offers infection prevention and control products comprising disinfectants, detergent wipes, cleaning and disinfection products, anti-microbial hand sanitizers, clinical waste containers, and sharps; patient hygiene solutions, such as skin cleansings, dry and moist patient wipes, and bed bath systems; surgical products, including bags for endoscopic retrieval of tissue, single-use instruments, custom procedure packs and trays, X-ray detectable swabs, and gauzes; and wound care solutions, such as tubular bandages, garments, hosiery and liner kits, and sterile gauze dressing products. It is also involved in the provision of logistics consultancy services; IT services; and trading activities. The company was founded in 1991 and is headquartered in Swindon, the United Kingdom.

5,670 Employees
Last Reported Date: 07/10/15
Founded in 1991

synergy health plc (SYR) Top Compensated Officers

Group Chief Executive Officer, Member of Seni...
Total Annual Compensation: 874.0K GBP
Group Finance Director, Member of Senior Exec...
Total Annual Compensation: 551.0K GBP
Group Chief Operating Officer, Member of Seni...
Total Annual Compensation: 529.0K GBP
Compensation as of Fiscal Year 2015.

synergy health plc (SYR) Key Developments

Synergy Health plc Announces Trading Update for the Quarter Ended June 28, 2015

Synergy Health plc announced trading update for the quarter ended June 28, 2015. The company reported revenue for the three months to 28 June 2015 increased by 9% to £104.2 million (first quarter of 2014/15 £95.6 million). Underlying revenue, excluding currency effects, increased by 10.7%. Operating margin remains 60 basis points higher than the comparative period.

Synergy Health plc Not Pay Interim and Final Dividend

Synergy Health plc announced that as a result of the proposed combination with STERIS, the board chose not to pay an interim dividend to shareholders against the company paid 8.57 pence per share in 2014, and is not proposing to pay a final dividend to shareholders against 2014 total dividend of 22.77 pence per share. The board will continue to keep its dividend policy under review.

Synergy Health plc Reports Preliminary Consolidated Results for the Year Ended March 29, 2015

Synergy Health plc reported preliminary consolidated results for the year ended March 29, 2015. For the period, the company reported revenue of £408,824,000 against £380,453,000 a year ago. Operating profit was £50,143,000 against £49,503,000 a year ago. Profit before tax was £43,579,000 against £42,893,000 a year ago. Profit attributable to equity holders of the parent was £33,569,000 or 56.37 pence per diluted share against £33,949,000 or 57.05 pence per diluted share a year ago. Net cash generated from operating activities was £85,953,000 against £84,871,000 a year ago. Purchases of property, plant and equipment was £61,727,000 against £39,243,000 a year ago. Purchase of intangible assets was £1,718,000 against £1,671,000 a year ago. Adjusted operating profit was £64.6 million against £61.3 million a year ago. Adjusted profit before tax was £58.0 million against £54.7 million a year ago. Adjusted basic earnings per share were 75.50 pence against 70.59 pence a year ago. Net debt was £161.1 million against £147.6 million a year ago. Return on average capital employed (ROCE) increased to 12.4% compared to 12.0% a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYR:LN 1,589.00 GBp -36.00

SYR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almirall SA €17.07 EUR -0.41
Ironwood Pharmaceuticals Inc $11.00 USD 0.00
Nektar Therapeutics $10.79 USD -0.26
Sucampo Pharmaceuticals Inc $25.72 USD -1.14
Theravance Inc $14.04 USD +0.13
View Industry Companies
 

Industry Analysis

SYR

Industry Average

Valuation SYR Industry Range
Price/Earnings 29.8x
Price/Sales 2.4x
Price/Book 2.8x
Price/Cash Flow 23.6x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNERGY HEALTH PLC, please visit www.synergyhealthplc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.